Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Liu, Juanjuan ^a   Lin, Bei ^a   Hao, Yingying ^a   Qi, Yue ^a   Zhu, Liancheng ^a   Li, Feifei ^a   Liu, Dawo ^a   Cong, Jianping ^a   Zhang, Shulan ^a   Iwamori, Masao ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALPHA LEVO FUCOSIDASE; FUCOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; ENZYME INHIBITOR; GALACTOSIDE 2 ALPHA L FUCOSYLTRANSFERASE; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE; LEWIS Y ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; ATTENUATION; BLOOD GROUP LEWIS SYSTEM; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PLASMID; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; OVARY TUMOR; PHYSIOLOGY; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INHIBITORS; FEMALE; FUCOSYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; LEWIS BLOOD-GROUP SYSTEM; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 74849108223     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-154     Document Type: Article

References (47)

1. Specificity analysis of blood group Lewis-y {Le(y)} antibodies generatedagainst synthetic and natural Le(y) determinants. K Kitamura E Stockert P Garin-Chesa S Welt KO Llovd KL Armour TP Wallace WJ Harris FJ Carr LJ Old, Proc Natl Acad Sci USA 1994 91 12957 12961 10.1073/pnas.91.26.12957 7809154
2. Identification of an alpha3-fucosyltransferase and a novel alpha2-fucosyltransferase activity in cercariae of the schistosome Trichobilharzia ocellata: biosynthesis of the Fucalpha1 2Fucalpha1 3[Gal(NAc)beta1 4]GlcNAc sequence. CH Hokke AP Neeleman CA Koeleman DH van den Eijnden, Glycobiology 1998 8 393 406 10.1093/glycob/8.4.393 9499387
3. Activation-dependent expression of the blood group-related Lewis Y antigen on peripheral blood granulocytes. M Dettke G Plfi H Loibner, J Leukoc Biol 2000 68 511 514 11037972
4. Differential diagnosis between normal endometrium and endometrial hyperplasia with immunostaining cytology using anti-LeY monoclonal antibody. Y Arai M Nishida, Int J Gynecol Cancer 2003 13 42 46 10.1046/j.1525-1438.2003. 13009.x 12631219
5. High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas. Z Madjd T Parsons NF Watson I Spendlove I Ellis LG Durrant, Breast Cancer Res 2005 7 780 R787 10.1186/bcr1305 16168124
6. Expression of LeY and extended LeY blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues. YS Kim M Yuan SH Itzkowitz QB Sun T Kaizu A Palekar BF Trump S Hakomori, Cancer Res 1986 46 5985 5992 2428490
7. Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer. BW Yin CL Finstad K Kitamura MG Federici M Welshinger V Kudrvashov WJ Hoskins S Welt KO Lloyd, Int J Cancer 1996 65 406 412 10.1002/(SICI)1097-0215(19960208)65:4<406:AID-IJC2>3.0. CO;2-0 8621218
8. Alterations in the glyolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the 1,2-fucosyltransferase gene. M Iwamori K Tanaka K Kubushiro B Lin K Kiguchi I Ishiwata K Tsukazaki S Nozawa, Cancer Sci 2005 96 26 30 15649251
9. The effects of Lewis(y) antigen content on drug resistance to carboplatin in ovarian cancer line RMG-I. Y Zhao B Lin YY Hao LM Yan JJ Liu LC Zhu SL Zhang, Prog Biochem Biophys 2008 35 1175 1182
10. Erb receptors and signaling pathways in cancer. NE Hynes G MacDonald, Curr Opin Cell Biol 2009 21 185 193 10.1016/j.ceb.2008.12.010 19216065
11. Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway. A Matsumoto T Ichikawa K Nakao H Miyaaki K Hirano M Fujimito M Akiyama S Miuma E Ozawa H Shibata S Takeshita H Yamasaki M Ikeda N Kato K Eguchi, J Gastroenterol 2009 44 856 863 10.1007/s00535-009-0075-1 19436942
12. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. S Park D Zhao KJ Hatanpaa BE Mickey D Saha DA Boothman MD Story ET Wong S Burma MM Georgescu VM Rangenkar SS Chauncey AA Habib, Cancer Res 2009 69 4107 4111 10.1158/0008-5472.CAN-09-0474 19435890
13. ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839). EA Djerf C Trinks A Abdiu LK Thunell AL Hallbeck TM Walz, Melanoma Res 2009 19 156 166 10.1097/CMR. 0b013e32832c6339 19434003
14. Molecular targets of breast cancer: AKTing in concert. A Basu, Breast Cancer 2008 2 11 16 19430575
15. The Akt inhibitor tricirbine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. A Dieterie R Orth M Daubrawa A Grotemeier S Alers S Ullrich R Lammers S Wesselborg B Stork, Int J Cancer 2009 125 932 941 10.1002/ijc.24374 19422047
16. Mechanism by which H-2 g, a glucose analog of blood group H antigen, mediates angiogenesis. K Zhu MA Amin YY Zha LA Harlow AE Koch, Blood 2005 105 2343 2349 10.1182/blood-2004-08-3140 15498849
17. Effect of retionic acid on cell surface glycopeptides of cultured spontancously transformed mouse fibroblasts(BALB/c3T72-3 cells). W Sasak LM De Luca LD Dion CS Silverman-Jones, Cancer Res 1980 40 1944 1949 7371030
18. The p21 and PCNA partnership: a new twist for an old plot. C Prives V Gottifredi, Cell Cycle 2008 7 3840 3846 19066467
19. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. R Apweiler H Hermjakob N Sharon, Biochim Biophys Acta 1999 1473 4 8 10580125
20. Human glycogene cloning: focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase families. H Narimatsu, Curr Opin Struct Biol 2006 16 567 575 10.1016/j.sbi.2006.09.001 16979334
21. Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells. CA Aamoudse M Bax M Snchez-Hernndez JJ García-Vallejo Y van Koovk, Int J Cancer 2008 122 839 846 10.1002/ijc.23101 17957800
22. Glycosylation-Dependent Interactions of C-Type Lectin DC-SIGN with Colorectal Tumor-Associated Lewis Glycans Impair the Function and Differentiation of Monocyte-Derived Dendritic Cells. M Nonaka BY Ma R Murai N Nakamura M Baba N Kawasaki K Hodohara S Asano, J Immunol 2008 180 3347 3356 18292560
23. Galactomutarotase and other galactose-related genes are rapidly induced by retinoic acid in human myeloid cells. T Pai Q Chen Y Zhang R Zolfaqhari AC Ross, Biochemistry 2007 46 15198 151207 10.1021/bi701891t 18052213
24. Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression. MF Federici V Kudryashov PE Saigo CL Finstad KO Lloyd, Int J Cancer 1999 81 193 198 10.1002/(SICI)1097-0215(19990412)81:2<193:AID- IJC5>3.0.CO;2-S 10188718
25. Impact of alpha1,2-fucosyltransferase gene transfection on cancer related gene expression profile of human ovarian cancer cell line RMG-I. LC Zhu B Lin YY Hao FF Li B Diao SL Zhang, Ai Zheng 2008 27 934 941 18799031
26. Antibodies directed against Lewis-Y antigen inhibit signaling of Lewis-Y modified ErbB receptors. M Klinger H Farhan H Just H Drobny G Himmler H Loibner GC Mudde M Freissmuth V Sexl, Cancer Res 2004 64 1087 1093 10.1158/0008-5472. CAN-03-2435 14871842
27. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function. M Fraser T Bai BK Tsang, Int J Cancer 2008 22 534 546 10.1002/ijc.23086 (Pubitemid 350308944)
28. Resveratrol inhibits glucose metabolism in human ovarian cancer cells. A Kueck AW Opipari Jr KA Griffith L Tan M Choi J Huang H Wahl JR Liu, Gynecol Oncol 2007 103 450 457 10.1016/j.ygyno.2007.07.065 (Pubitemid 350160855)
29. Akt signaling: linking membrane events to life and death decisions. BA Hemmings, Science 1997 275 628 630 10.1126/science.275.5300.628 9019819
30. The role of activin A and Akt/GSK signaling in ovarian tumor biology. TV Do LA Kubba M Antenos AW Rademaker CD Sturgis TK Woodruff, Endocrinology 2008 149 3809 3816 10.1210/en.2007-1584 18450971
31. Current overview of the role of Akt in cancer studies via applied immunohistochemistry. V Shtilbans M Wu DE Burstein, Ann Diagn Pathol 2008 12 153 160 10.1016/j.anndiagpath.2007.12.001 18325479
32. Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer. J Woenckhaus K Steger K Sturm K Münstedt FE Franke I Fenic, Virchows Arch 2007 450 387 395 10.1007/s00428-006-0358-3 17377809
33. Expression of cell surface Lewis X and Y antigens and FUT mRNA is increased in Jurkat cells undergoing apoptosis. Y Azuma M Ito A Taniguchi K Matsumoto, Biochim Biophys Acta 2004 1672 157 163 15182935
34. Ley glycolipid-recognizing monoclonal antibody inhibits procoagulant activity and metastasis of human adenocarcinoma. H Inufusa T Adachi T Kivokawa Y Nakatani T Wakano M Nakamura K Okuno H Shiozaki S Yamamoto M Suzuki O Ando M Kurimoto M Miyake M Yasutomi, Int J Oncol 2001 19 941 946 11604991
35. Role for alpha1,2-fucosyltransferase and histo-blood group antigen H type 2 in resistance of rat colon carcinoma cells to 5-fluorouracil. S Cordel C Goupille E Hallouin K Meflah J Le Pendu, Int J Cancer 2000 85 142 148 10.1002/(SICI)1097-0215(20000101)85:1<142:AID-IJC24>3.0.CO;2-K 10585597
36. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. C De Bolás M Garrido FX Real, Gastroenterology 1995 109 723 734 10.1016/0016-5085(95)90379-8 7657100
37. Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. A Basu U Murthy U Rodeck M Herlyn L Mattes M Das, Cancer Res 1987 47 2531 2536 2436750
38. Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppression] of activation. XQ Wang P Sun M O'Gorman T Tai AS Paller, Glycobiology 2001 11 515 522 10.1093/glycob/11.7.515 11447130
39. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. X Wang S Zhang GT MacLennan JN Eble A Lopez-Beltran XJ Yang CX Pan H Zhou R Montironi L Cheng, Clin Cancer Res 2007 13 953 957 10.1158/1078-0432.CCR-06-2167 17289890
40. N-Acetylglucosaminyl-transferase V modifies the signaling pathway of epidermal growth factor receptor. P Guo QY Wang HB Guo ZH Shen HL Chen, Cell Mol Life Sci 2004 61 1975 1804 10.1007/s00018-004-4122-z 15289938
41. Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways. MD Maines, Antioxid Redox Signal 2007 9 2187 2195 10.1089/ars.2007.1805 17919068
42. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. M Campbell WE Allen C Sawyer B Vanhaesebroeck ER Trimble, Circ Res 2004 95 380 388 10.1161/01.RES.0000138019.82184.5d 15242975
43. TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. MM Martin JA Buckenberger J Jiang GE Malana DL Knoell DS Feldman TS Elton, Am J Physiol Lung Cell Mol Physiol 2007 293 790 L799 10.1152/ajplung.00099.2007 17601799
44. Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice. JA Westwood MJ Smyth MW Teng M Moeller JA Trapani AM Scott FE Smyth GA Cartwright BE Power D Hönemann HM Prince PK Darcy MH Kershaw, Proc Natl Acad Sci USA 2005 102 19051 19056 10.1073/pnas.0504312102 16365285
45. Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. MM Halloran WW Carley PJ Polverini CJ Haskell S Phan BJ Anderson JM Woods PL Campbell MV Volin AE Bäcker AE Koch, J Immunol 2000 164 4868 4877 10779796
46. Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis y conjugates in mice. V Kudryashow PW Glunz LJ Williams S Hintermann SJ Danishefsky KO Lloyd, Proc Natl Acad Sci USA 2001 98 3264 3269 10.1073/pnas.051623598 11248067
47. Cancer vaccines targeting carbohydrate antigens. PO Livingston G Ragupathi, Hum Vaccin 2006 2 137 143 17012906